$NGSX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NeurogesX Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NeurogesX Inc. Get notifications about new insider transactions in NeurogesX Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 25 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 6.05 | 3,750 | 22,688 | 1,406,772 | 1.4 M to 1.4 M (-0.27 %) |
Jun 25 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 6.08 | 1,795 | 10,914 | 753,580 | 755.4 K to 753.6 K (-0.24 %) |
Jun 25 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 6.10 | 8,800 | 53,680 | 755,375 | 764.2 K to 755.4 K (-1.15 %) |
Jun 25 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 6.05 | 2,037 | 12,324 | 764,175 | 766.2 K to 764.2 K (-0.27 %) |
Jun 25 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.90 | 5,744 | 33,890 | 1,410,522 | 1.4 M to 1.4 M (-0.41 %) |
Jun 25 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 6.77 | 17,445 | 118,103 | 1,416,266 | 1.4 M to 1.4 M (-1.22 %) |
Jun 25 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 5.90 | 3,119 | 18,402 | 766,212 | 769.3 K to 766.2 K (-0.41 %) |
Jun 25 2009 | NGSX | NeurogesX Inc | Flynn James E | 10% Owner | Sell | S | 6.77 | 9,475 | 64,146 | 769,331 | 778.8 K to 769.3 K (-1.22 %) |
May 29 2009 | NGSX | NeurogesX Inc | Kurtz Neil M | Director | Option Exercise | A | 5.51 | 5,000 | 27,550 | 25,666 | |
May 29 2009 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 5.51 | 5,000 | 27,550 | 26,333 | |
May 29 2009 | NGSX | NeurogesX Inc | NELSEN ROBERT | Director | Option Exercise | A | 5.51 | 5,000 | 27,550 | 15,000 | |
May 29 2009 | NGSX | NeurogesX Inc | PEACOCK BRUCE | Director | Option Exercise | A | 5.51 | 5,000 | 27,550 | 23,333 | |
Apr 27 2009 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Gift | G | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
Apr 27 2009 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Gift | G | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
Apr 27 2009 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Gift | G | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
Apr 27 2009 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Gift | G | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
Apr 27 2009 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Gift | G | 0.00 | 4,000 | 0 | 34,419 | 38.4 K to 34.4 K (-10.41 %) |
Jan 20 2009 | NGSX | NeurogesX Inc | Bley Keith R | SVP Nonclinical R & ... | Option Exercise | A | 1.25 | 30,000 | 37,500 | 30,000 | |
Jan 20 2009 | NGSX | NeurogesX Inc | Bley Keith R | SVP Nonclinical R & ... | Option Exercise | A | 1.25 | 28,172 | 35,215 | 28,172 | |
Jan 20 2009 | NGSX | NeurogesX Inc | DiTonno Anthony A | President, CEO and ... | Option Exercise | A | 1.25 | 50,000 | 62,500 | 50,000 | |
Jan 20 2009 | NGSX | NeurogesX Inc | DiTonno Anthony A | President, CEO and ... | Option Exercise | A | 1.25 | 80,000 | 100,000 | 80,000 | |
Jan 20 2009 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Option Exercise | A | 1.25 | 30,000 | 37,500 | 30,000 | |
Jan 20 2009 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Option Exercise | A | 1.25 | 29,520 | 36,900 | 29,520 | |
Jan 20 2009 | NGSX | NeurogesX Inc | Rinne Susan P | VP, Regulatory Affa ... | Option Exercise | A | 1.25 | 30,000 | 37,500 | 30,000 | |
Jan 20 2009 | NGSX | NeurogesX Inc | Rinne Susan P | VP, Regulatory Affa ... | Option Exercise | A | 1.25 | 20,000 | 25,000 | 20,000 | |
Jan 20 2009 | NGSX | NeurogesX Inc | Markels Michael | VP, Commercial Ops ... | Option Exercise | A | 1.25 | 25,000 | 31,250 | 25,000 | |
Jan 20 2009 | NGSX | NeurogesX Inc | Markels Michael | VP, Commercial Ops ... | Option Exercise | A | 1.25 | 20,000 | 25,000 | 20,000 | |
Jan 20 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | A | 1.25 | 30,000 | 37,500 | 30,000 | |
Jan 20 2009 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | A | 1.25 | 60,000 | 75,000 | 60,000 | |
Jan 20 2009 | NGSX | NeurogesX Inc | Kawahata Russell T | V P, Pharmaceutical ... | Option Exercise | A | 1.25 | 25,000 | 31,250 | 25,000 | |
Jan 20 2009 | NGSX | NeurogesX Inc | Kawahata Russell T | V P, Pharmaceutical ... | Option Exercise | A | 1.25 | 19,200 | 24,000 | 19,200 | |
Dec 12 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 1.68 | 100 | 168 | 33,022 | 32.9 K to 33 K (+0.30 %) |
Dec 12 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 1.67 | 100 | 167 | 32,922 | 32.8 K to 32.9 K (+0.30 %) |
Dec 11 2008 | NGSX | NeurogesX Inc | Markels Michael | VP, Commercial Ops ... | Buy | P | 1.50 | 96 | 144 | 15,645 | 15.5 K to 15.6 K (+0.62 %) |
Dec 11 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Buy | P | 1.67 | 500 | 834 | 38,419 | 37.9 K to 38.4 K (+1.32 %) |
Dec 09 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 1.80 | 100 | 180 | 32,822 | 32.7 K to 32.8 K (+0.31 %) |
Dec 09 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 1.79 | 200 | 358 | 32,722 | 32.5 K to 32.7 K (+0.61 %) |
Dec 09 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 1.60 | 100 | 160 | 32,522 | 32.4 K to 32.5 K (+0.31 %) |
Dec 09 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 1.79 | 200 | 358 | 32,422 | 32.2 K to 32.4 K (+0.62 %) |
Dec 09 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 1.64 | 400 | 656 | 32,222 | 31.8 K to 32.2 K (+1.26 %) |
Dec 09 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 1.51 | 100 | 151 | 31,822 | 31.7 K to 31.8 K (+0.32 %) |
Dec 09 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 1.82 | 322 | 586 | 31,722 | 31.4 K to 31.7 K (+1.03 %) |
Dec 09 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 1.80 | 178 | 320 | 31,400 | 31.2 K to 31.4 K (+0.57 %) |
Dec 09 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 1.76 | 1,400 | 2,464 | 31,222 | 29.8 K to 31.2 K (+4.69 %) |
Dec 09 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 1.72 | 400 | 688 | 29,822 | 29.4 K to 29.8 K (+1.36 %) |
Dec 08 2008 | NGSX | NeurogesX Inc | Markels Michael | VP, Commercial Ops ... | Buy | P | 1.80 | 1,000 | 1,800 | 15,549 | 14.5 K to 15.5 K (+6.87 %) |
Dec 08 2008 | NGSX | NeurogesX Inc | Markels Michael | VP, Commercial Ops ... | Buy | P | 1.51 | 1,000 | 1,510 | 14,549 | 13.5 K to 14.5 K (+7.38 %) |
Dec 03 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 1.44 | 401 | 577 | 29,422 | 29 K to 29.4 K (+1.38 %) |
Dec 03 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 1.22 | 600 | 732 | 29,021 | 28.4 K to 29 K (+2.11 %) |
Dec 03 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 1.21 | 600 | 726 | 28,421 | 27.8 K to 28.4 K (+2.16 %) |
Dec 03 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Buy | P | 1.60 | 267 | 427 | 37,919 | 37.7 K to 37.9 K (+0.71 %) |
Dec 03 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Buy | P | 1.59 | 233 | 370 | 37,652 | 37.4 K to 37.7 K (+0.62 %) |
Dec 03 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Buy | P | 1.50 | 1,500 | 2,250 | 37,419 | 35.9 K to 37.4 K (+4.18 %) |
Dec 03 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Buy | P | 1.30 | 400 | 520 | 35,919 | 35.5 K to 35.9 K (+1.13 %) |
Dec 03 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Buy | P | 1.39 | 464 | 645 | 35,519 | 35.1 K to 35.5 K (+1.32 %) |
Nov 25 2008 | NGSX | NeurogesX Inc | Markels Michael | VP, Commercial Ops ... | Buy | P | 1.51 | 1,700 | 2,567 | 13,549 | 11.8 K to 13.5 K (+14.35 %) |
Nov 25 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Buy | P | 1.60 | 2,000 | 3,200 | 35,055 | 33.1 K to 35.1 K (+6.05 %) |
Nov 20 2008 | NGSX | NeurogesX Inc | Markels Michael | VP, Commercial Ops ... | Buy | P | 1.50 | 499 | 749 | 11,849 | 11.4 K to 11.8 K (+4.40 %) |
Nov 20 2008 | NGSX | NeurogesX Inc | Markels Michael | VP, Commercial Ops ... | Buy | P | 1.50 | 502 | 753 | 11,350 | 10.8 K to 11.4 K (+4.63 %) |
Nov 20 2008 | NGSX | NeurogesX Inc | Markels Michael | VP, Commercial Ops ... | Buy | P | 1.50 | 699 | 1,049 | 10,848 | 10.1 K to 10.8 K (+6.89 %) |
Nov 20 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Buy | P | 1.55 | 2,000 | 3,100 | 33,055 | 31.1 K to 33.1 K (+6.44 %) |
Nov 20 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Buy | P | 1.80 | 500 | 900 | 31,055 | 30.6 K to 31.1 K (+1.64 %) |
Nov 20 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Buy | P | 1.79 | 100 | 179 | 30,555 | 30.5 K to 30.6 K (+0.33 %) |
Nov 20 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Buy | P | 1.77 | 195 | 345 | 30,455 | 30.3 K to 30.5 K (+0.64 %) |
Nov 20 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Buy | P | 1.75 | 100 | 175 | 30,260 | 30.2 K to 30.3 K (+0.33 %) |
Nov 20 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Buy | P | 1.70 | 17 | 29 | 30,160 | 30.1 K to 30.2 K (+0.06 %) |
Nov 20 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Buy | P | 1.60 | 100 | 160 | 30,143 | 30 K to 30.1 K (+0.33 %) |
Nov 14 2008 | NGSX | NeurogesX Inc | Markels Michael | VP, Business Develo ... | Buy | P | 1.55 | 1,450 | 2,248 | 8,816 | 7.4 K to 8.8 K (+19.69 %) |
Nov 14 2008 | NGSX | NeurogesX Inc | Markels Michael | VP, Business Develo ... | Buy | P | 1.75 | 800 | 1,400 | 7,366 | 6.6 K to 7.4 K (+12.18 %) |
Nov 14 2008 | NGSX | NeurogesX Inc | Markels Michael | VP, Business Develo ... | Buy | P | 1.73 | 800 | 1,381 | 6,566 | 5.8 K to 6.6 K (+13.87 %) |
Nov 14 2008 | NGSX | NeurogesX Inc | Markels Michael | VP, Business Develo ... | Buy | P | 1.54 | 100 | 154 | 5,766 | 5.7 K to 5.8 K (+1.76 %) |
May 30 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 3.37 | 5,000 | 16,850 | 21,333 | |
May 30 2008 | NGSX | NeurogesX Inc | Kurtz Neil M | Director | Option Exercise | A | 3.37 | 5,000 | 16,850 | 20,666 | |
May 30 2008 | NGSX | NeurogesX Inc | NELSEN ROBERT | Director | Option Exercise | A | 3.37 | 5,000 | 16,850 | 10,000 | |
May 30 2008 | NGSX | NeurogesX Inc | PEACOCK BRUCE | Director | Option Exercise | A | 3.37 | 5,000 | 16,850 | 18,333 | |
May 22 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 3.54 | 100 | 354 | 27,821 | 27.7 K to 27.8 K (+0.36 %) |
May 22 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 3.54 | 2,800 | 9,912 | 27,721 | 24.9 K to 27.7 K (+11.24 %) |
May 22 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 3.53 | 100 | 353 | 24,921 | 24.8 K to 24.9 K (+0.40 %) |
May 22 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 3.55 | 304 | 1,079 | 24,821 | 24.5 K to 24.8 K (+1.24 %) |
May 22 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 3.51 | 100 | 351 | 24,517 | 24.4 K to 24.5 K (+0.41 %) |
May 22 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 3.53 | 200 | 706 | 24,417 | 24.2 K to 24.4 K (+0.83 %) |
May 22 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 3.48 | 1,396 | 4,858 | 24,217 | 22.8 K to 24.2 K (+6.12 %) |
May 22 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 3.50 | 2,000 | 7,000 | 22,821 | 20.8 K to 22.8 K (+9.61 %) |
May 22 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 3.54 | 1,300 | 4,602 | 20,821 | 19.5 K to 20.8 K (+6.66 %) |
May 22 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 3.54 | 700 | 2,475 | 19,521 | 18.8 K to 19.5 K (+3.72 %) |
May 22 2008 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 3.50 | 3,000 | 10,500 | 18,821 | 15.8 K to 18.8 K (+18.96 %) |
May 14 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Option Exercise | M | 1.80 | 12,000 | 21,600 | 0 | |
May 14 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Buy | M | 1.80 | 12,000 | 21,600 | 27,377 | 15.4 K to 27.4 K (+78.04 %) |
Apr 22 2008 | NGSX | NeurogesX Inc | DiTonno Anthony A | President, CEO and ... | Option Exercise | M | 2.70 | 21,667 | 58,501 | 64,999 | |
Apr 22 2008 | NGSX | NeurogesX Inc | DiTonno Anthony A | President, CEO and ... | Buy | M | 2.70 | 21,667 | 58,501 | 106,333 | 84.7 K to 106.3 K (+25.59 %) |
Jan 14 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Option Exercise | A | 5.43 | 25,000 | 135,750 | 25,000 | |
Jan 14 2008 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | A | 5.43 | 25,000 | 135,750 | 25,000 | |
Jan 03 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Option Exercise | M | 1.80 | 8,000 | 14,400 | 12,000 | |
Jan 03 2008 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Financial Off ... | Buy | M | 1.80 | 8,000 | 14,400 | 15,377 | 7.4 K to 15.4 K (+108.45 %) |
Dec 27 2007 | NGSX | NeurogesX Inc | ARCH VENTURE PARTNERS V LP | 10% Owner | Option Exercise | P | 8.03 | 114,651 | 920,648 | 114,651 | |
Dec 27 2007 | NGSX | NeurogesX Inc | ARCH VENTURE PARTNERS V LP | 10% Owner | Buy | P | 6.18 | 382,170 | 2,361,811 | 2,443,591 | 2.1 M to 2.4 M (+18.54 %) |
Nov 21 2007 | NGSX | NeurogesX Inc | Kawahata Russell T | V P, Pharmaceutical ... | Option Exercise | A | 6.21 | 40,000 | 248,400 | 40,000 | |
Nov 21 2007 | NGSX | NeurogesX Inc | Markels Michael | VP, Business Develo ... | Buy | P | 6.48 | 1,700 | 11,016 | 4,333 | 2.6 K to 4.3 K (+64.57 %) |
Nov 21 2007 | NGSX | NeurogesX Inc | Markels Michael | VP, Business Develo ... | Buy | P | 6.42 | 1,000 | 6,420 | 2,633 | 1.6 K to 2.6 K (+61.24 %) |
Nov 21 2007 | NGSX | NeurogesX Inc | Markels Michael | VP, Business Develo ... | Buy | P | 6.36 | 200 | 1,272 | 1,633 | 1.4 K to 1.6 K (+13.96 %) |
Nov 21 2007 | NGSX | NeurogesX Inc | Markels Michael | VP, Business Develo ... | Buy | P | 6.35 | 100 | 635 | 1,433 | 1.3 K to 1.4 K (+7.50 %) |
Oct 04 2007 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 8.63 | 8,000 | 69,040 | 8,000 | |
Oct 04 2007 | NGSX | NeurogesX Inc | Bley Keith R | SVP Nonclinical R & ... | Option Exercise | A | 8.63 | 10,000 | 86,300 | 10,000 | |
Oct 04 2007 | NGSX | NeurogesX Inc | Kurtz Neil M | Director | Option Exercise | A | 8.63 | 4,000 | 34,520 | 4,000 | |
Oct 04 2007 | NGSX | NeurogesX Inc | DiTonno Anthony A | President, CEO and ... | Option Exercise | A | 8.63 | 80,000 | 690,400 | 80,000 | |
Oct 04 2007 | NGSX | NeurogesX Inc | Ghiglieri Stephen F | Chief Finanacial Of ... | Option Exercise | A | 8.63 | 25,000 | 215,750 | 25,000 | |
Oct 04 2007 | NGSX | NeurogesX Inc | Harder Karen J | SVP, Reg Affairs | Option Exercise | A | 8.63 | 10,000 | 86,300 | 10,000 | |
Oct 04 2007 | NGSX | NeurogesX Inc | Markels Michael | VP, Business Develo ... | Option Exercise | A | 8.63 | 10,000 | 86,300 | 10,000 | |
Oct 04 2007 | NGSX | NeurogesX Inc | Rinne Susan P | VP, Regulatory Affa ... | Option Exercise | A | 8.63 | 50,000 | 431,500 | 50,000 | |
Oct 04 2007 | NGSX | NeurogesX Inc | Tobias Jeffrey K | Chief Medical Offic ... | Option Exercise | A | 8.63 | 25,000 | 215,750 | 25,000 | |
Sep 11 2007 | NGSX | NeurogesX Inc | PEACOCK BRUCE | Director | Option Exercise | A | 8.58 | 13,333 | 114,397 | 13,333 | |
Sep 11 2007 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 8.74 | 900 | 7,866 | 15,821 | 14.9 K to 15.8 K (+6.03 %) |
Sep 11 2007 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 8.72 | 100 | 872 | 14,921 | 14.8 K to 14.9 K (+0.67 %) |
Sep 11 2007 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 8.62 | 900 | 7,758 | 14,821 | 13.9 K to 14.8 K (+6.47 %) |
Sep 11 2007 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Buy | P | 8.61 | 100 | 861 | 13,921 | 13.8 K to 13.9 K (+0.72 %) |
Jun 12 2007 | NGSX | NeurogesX Inc | Kurtz Neil M | Director | Option Exercise | A | 7.54 | 5,000 | 37,700 | 11,666 | |
Jun 11 2007 | NGSX | NeurogesX Inc | MARDUEL ALIX | Director | Option Exercise | A | 7.54 | 5,000 | 37,700 | 5,000 | |
Jun 11 2007 | NGSX | NeurogesX Inc | TURNER DANIEL K III | Director | Option Exercise | A | 7.54 | 5,000 | 37,700 | 5,000 | |
Jun 11 2007 | NGSX | NeurogesX Inc | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 7.54 | 5,000 | 37,700 | 8,333 | |
Jun 08 2007 | NGSX | NeurogesX Inc | NELSEN ROBERT | Director | Option Exercise | A | 7.54 | 5,000 | 37,700 | 5,000 | |
May 09 2007 | NGSX | NeurogesX Inc | ARCH VENTURE FUND V LP | 10% Owner | Option Exercise | C | 0.00 | 1,876,992 | 0 | 0 | |
May 09 2007 | NGSX | NeurogesX Inc | ARCH VENTURE FUND V LP | 10% Owner | Option Exercise | C | 0.00 | 2,339,915 | 0 | 0 | |
May 09 2007 | NGSX | NeurogesX Inc | ARCH VENTURE FUND V LP | 10% Owner | Option Exercise | C | 0.00 | 2,666,667 | 0 | 0 | |
May 09 2007 | NGSX | NeurogesX Inc | ARCH VENTURE FUND V LP | 10% Owner | Option Exercise | C | 0.00 | 50,520 | 0 | 0 | |
May 09 2007 | NGSX | NeurogesX Inc | ARCH VENTURE FUND V LP | 10% Owner | Option Exercise | C | 0.00 | 56,900 | 0 | 0 | |
May 09 2007 | NGSX | NeurogesX Inc | ARCH VENTURE FUND V LP | 10% Owner | Option Exercise | C | 0.00 | 30,347 | 0 | 0 | |
May 09 2007 | NGSX | NeurogesX Inc | ARCH VENTURE FUND V LP | 10% Owner | Option Exercise | C | 0.00 | 27,312 | 0 | 0 | |
May 09 2007 | NGSX | NeurogesX Inc | ARCH VENTURE FUND V LP | 10% Owner | Option Exercise | C | 0.00 | 7,497,552 | 0 | 0 | |
May 09 2007 | NGSX | NeurogesX Inc | ARCH VENTURE FUND V LP | 10% Owner | Option Exercise | C | 0.00 | 9,943,100 | 0 | 0 | |
May 09 2007 | NGSX | NeurogesX Inc | ARCH VENTURE FUND V LP | 10% Owner | Option Exercise | C | 0.00 | 5,302,986 | 0 | 0 | |
May 09 2007 | NGSX | NeurogesX Inc | ARCH VENTURE FUND V LP | 10% Owner | Option Exercise | C | 0.00 | 4,772,668 | 0 | 0 | |
May 09 2007 | NGSX | NeurogesX Inc | ARCH VENTURE FUND V LP | 10% Owner | Buy | C | 0.00 | 458,903 | 0 | 458,903 | 0 to 458.9 K |
May 09 2007 | NGSX | NeurogesX Inc | ARCH VENTURE FUND V LP | 10% Owner | Buy | C | 0.00 | 11,004 | 0 | 11,004 | 0 to 11 K |
May 09 2007 | NGSX | NeurogesX Inc | ARCH VENTURE FUND V LP | 10% Owner | Buy | C | 0.00 | 1,834,421 | 0 | 2,061,421 | 227 K to 2.1 M (+808.11 %) |
May 08 2007 | NGSX | NeurogesX Inc | TURNER DANIEL K III | Director | Option Exercise | C | 0.00 | 2,753,508 | 0 | 0 | |
May 08 2007 | NGSX | NeurogesX Inc | TURNER DANIEL K III | Director | Option Exercise | C | 0.00 | 1,144,494 | 0 | 0 | |
May 08 2007 | NGSX | NeurogesX Inc | TURNER DANIEL K III | Director | Option Exercise | C | 0.00 | 4,568,000 | 0 | 0 | |
May 08 2007 | NGSX | NeurogesX Inc | TURNER DANIEL K III | Director | Option Exercise | C | 0.00 | 1,898,666 | 0 | 0 | |
May 08 2007 | NGSX | NeurogesX Inc | TURNER DANIEL K III | Director | Option Exercise | C | 0.00 | 2,333,333 | 0 | 0 | |
May 08 2007 | NGSX | NeurogesX Inc | TURNER DANIEL K III | Director | Option Exercise | C | 0.00 | 1,600,000 | 0 | 0 | |
May 08 2007 | NGSX | NeurogesX Inc | TURNER DANIEL K III | Director | Buy | C | 0.00 | 488,100 | 0 | 488,100 | 0 to 488.1 K |
May 08 2007 | NGSX | NeurogesX Inc | TURNER DANIEL K III | Director | Buy | C | 0.00 | 465,099 | 0 | 465,099 | 0 to 465.1 K |
May 08 2007 | NGSX | NeurogesX Inc | MARDUEL ALIX | Director | Option Exercise | C | 0.00 | 7,099,188 | 0 | 0 | |
May 08 2007 | NGSX | NeurogesX Inc | MARDUEL ALIX | Director | Option Exercise | C | 0.00 | 8,642,667 | 0 | 0 | |
May 08 2007 | NGSX | NeurogesX Inc | MARDUEL ALIX | Director | Option Exercise | C | 0.00 | 5,333,333 | 0 | 0 | |
May 08 2007 | NGSX | NeurogesX Inc | MARDUEL ALIX | Director | Option Exercise | C | 0.00 | 4,960,000 | 0 | 0 | |
May 08 2007 | NGSX | NeurogesX Inc | MARDUEL ALIX | Director | Buy | C | 0.00 | 1,735,673 | 0 | 1,735,673 | 0 to 1.7 M |
May 08 2007 | NGSX | NeurogesX Inc | ALTA BIOPHARMA MANAGEMENT III ... | 10% Owner | Option Exercise | C | 0.00 | 7,099,188 | 0 | 0 | |
May 08 2007 | NGSX | NeurogesX Inc | ALTA BIOPHARMA MANAGEMENT III ... | 10% Owner | Option Exercise | C | 0.00 | 8,642,667 | 0 | 0 | |
May 08 2007 | NGSX | NeurogesX Inc | ALTA BIOPHARMA MANAGEMENT III ... | 10% Owner | Option Exercise | C | 0.00 | 5,333,333 | 0 | 0 |